Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure is a research paper published in JACC Heart Failure (2022). On theSindex it has a DataRank of 1.3. It has been cited 34 times, with 26 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0.808
From 22 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 26 citers.
National Heart, Lung, and Blood Institute
Grant: U10 HL084904
National Heart, Lung, and Blood Institute
Grant: U10 HL110297
National Heart, Lung, and Blood Institute
Grant: U10 HL110262
National Heart, Lung, and Blood Institute
Grant: U10 HL110309
National Heart, Lung, and Blood Institute
Grant: U10 HL110338
National Heart, Lung, and Blood Institute
Grant: U10 HL110302
National Heart, Lung, and Blood Institute
Grant: U10 HL110312
National Heart, Lung, and Blood Institute
Grant: U10 HL110342
National Heart, Lung, and Blood Institute
Grant: U10 HL110336
National Heart, Lung, and Blood Institute
Grant: U10 HL110337
FWCI
4.92
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 1 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 2 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 2 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 3 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 3 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 4 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Additional file 4 of Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials